{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:28:20Z","timestamp":1764782900393},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.vaccine.2005.07.056","type":"journal-article","created":{"date-parts":[[2005,8,4]],"date-time":"2005-08-04T03:13:47Z","timestamp":1123125227000},"page":"36-44","source":"Crossref","is-referenced-by-count":32,"title":["Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis"],"prefix":"10.1016","volume":"24","author":[{"given":"Holly E.","family":"Humphries","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannette N.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona","family":"Blackstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith A.","family":"Jolley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho M.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron","family":"Christodoulides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Heckels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.07.056_bib1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1099\/0022-1317-51-9-717","article-title":"Impact of meningococcal C conjugate vaccine in the UK","volume":"51","author":"Balmer","year":"2002","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.056_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1099\/00222615-43-5-335","article-title":"Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease","volume":"43","author":"Idanpaan-Heikkila","year":"1995","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.056_bib3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"ii","author":"Finne","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.07.056_bib4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/IAI.51.2.571-578.1986","article-title":"Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting","volume":"51","author":"Wedege","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.056_bib5","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/IAI.62.10.4419-4424.1994","article-title":"Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy","volume":"62","author":"Milagres","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.056_bib6","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/IAI.63.12.4642-4652.1995","article-title":"Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine","volume":"63","author":"Rosenqvist","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.056_bib7","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1128\/IAI.64.7.2745-2751.1996","article-title":"Specificity of human bactericidal antibodies against PorA P1.7, 16 induced with a hexavalent meningococcal outer membrane vesicle vaccine","volume":"64","author":"Rouppe van der Voort","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.056_bib8","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1128\/IAI.59.9.2963-2971.1991","article-title":"Topology of outer membrane porins in pathogenic Neisseria spp","volume":"59","author":"van der Ley","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.056_bib9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2958.1993.tb01141.x","article-title":"Class 1 outer membrane protein of Neisseria meningitidis: epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology","volume":"7","author":"McGuinness","year":"1993","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.056_bib10","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.07.056_bib11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"Efficacy, safety, and immunogenicity of a meningococcal group B (15 P1.3) outer membrane protein vaccine in Iquique, Chile","volume":"13","author":"Boslego","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.056_bib12","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0140-6736(92)93086-3","article-title":"Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil","volume":"340","author":"Demoraes","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.07.056_bib13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1086\/514232","article-title":"Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland","volume":"177","author":"Perkins","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.056_bib14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00006454-199509000-00013","article-title":"The antimeningococcal vaccine VA-MENGOC-BC induced poor serum and salivary antibody-response in young Brazilian children","volume":"14","author":"Carbonare","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2005.07.056_bib15","first-page":"U1015","article-title":"The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic","volume":"117","author":"Sexton","year":"2004","journal-title":"NZ Med J"},{"key":"10.1016\/j.vaccine.2005.07.056_bib16","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.vaccine.2005.01.061","article-title":"From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease","volume":"23","author":"O\u2019Hallahan","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.056_bib17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0264-410X(95)98264-B","article-title":"Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine","volume":"13","author":"van der Ley","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.056_bib18","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0264-410X(96)00020-5","article-title":"Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine","volume":"14","author":"Claassen","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.056_bib19","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0264-410X(96)00001-1","article-title":"Phase-I clinical-trial with a hexavalent PorA containing meningococcal outer-membrane vesicle vaccine","volume":"14","author":"Peeters","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.056_bib20","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1016\/S0264-410X(99)00044-4","article-title":"Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins","volume":"17","author":"Cartwright","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.056_bib21","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0264-410X(02)00546-7","article-title":"Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes","volume":"21","author":"Arigita","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.056_bib22","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1099\/00221287-144-11-3027","article-title":"Immunisation with recombinant class 1 outer membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci","volume":"144","author":"Christodoulides","year":"1998","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2005.07.056_bib23","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.vaccine.2003.09.042","article-title":"Recombinant meningococcal PorA protein, expressed using a vector system with potential for human vaccination, induces a bactericidal immune response","volume":"22","author":"Humphries","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.056_bib24","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/0264-410X(95)00101-6","article-title":"The antibody response to a prototype liposome vaccine containing Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis","volume":"13","author":"Idanpaan-Heikkila","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.056_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1574-695X.2000.tb01434.x","article-title":"Immunogenicity of in vitro folded outer membrane protein PorA of Neisseria meningitidis","volume":"27","author":"Jansen","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.056_bib26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/mpat.1995.0038","article-title":"The Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis and reconstituted into phospholipid vesicles elicits antibodies to native P1 epitopes","volume":"18","author":"Muttilainen","year":"1995","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2005.07.056_bib27","series-title":"Molecular cloning\u2014a laboratory manual","author":"Sambrook","year":"1989"},{"key":"10.1016\/j.vaccine.2005.07.056_bib28","first-page":"2483","article-title":"Variation in the expression of pili and outer membrane protein by Neisseria meningitidis during the course of meningococcal infection","volume":"132","author":"Tinsley","year":"1986","journal-title":"J Gen Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.056_bib29","series-title":"Recombinant proteins in vaccine development","first-page":"167","article-title":"Meningococcal vaccines","year":"2001"},{"key":"10.1016\/j.vaccine.2005.07.056_bib30","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1006\/mpat.1996.0079","article-title":"Expression of Neisseria meningitidis class 1 porin as a fusion protein in Escherichia coli: the influence of liposomes and adjuvants on the production of a bactericidal immune response","volume":"21","author":"Ward","year":"1996","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2005.07.056_bib31","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/0140-6736(91)91297-8","article-title":"Point mutation in meningococcal porA gene associated with increased endemic disease","volume":"337","author":"McGuinness","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.07.056_bib32","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1099\/00221287-139-8-1729","article-title":"Immunisation with synthetic peptides containing epitopes of the class 1 outer membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunisation with a cyclic peptide","volume":"139","author":"Christodoulides","year":"1993","journal-title":"J Gen Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.056_bib33","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/315352","article-title":"Lack of immunity in university students prior to an outbreak of serogroup C meningococcal infection","volume":"181","author":"Jones","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.056_bib34","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1128\/IAI.69.6.3809-3816.2001","article-title":"Immunisation with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci","volume":"69","author":"Jolley","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.056_bib35","first-page":"R55","article-title":"Meningococcal disease in England and Wales: 1995","volume":"7","author":"Kaczmarski","year":"1997","journal-title":"Commun Dis Rep CDR Rev"},{"key":"10.1016\/j.vaccine.2005.07.056_bib36","first-page":"2269","article-title":"The potential protective effect of immunization with outer membrane protein I from Neisseria gonorrhoeae","volume":"135","author":"Heckels","year":"1989","journal-title":"J Gen Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.056_bib37","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0264-410X(01)00371-1","article-title":"Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine","volume":"20","author":"de Kleijn","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.056_bib38","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1128\/IAI.70.8.4028-4034.2002","article-title":"Immunisation with recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis","volume":"70","author":"Wright","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.056_bib39","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1128\/IAI.71.11.6367-6371.2003","article-title":"Relative immunogenicity of PorA subtypes in a multivalent Neisseria meningitidis vaccine is not dependent on presentation form","volume":"71","author":"Luijkx","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.056_bib40","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0005-2736(00)00155-3","article-title":"Biochemical and biophysical characterization of in vitro folded outer membrane porin PorA of Neisseria meningitidis","volume":"1464","author":"Jansen","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2005.07.056_bib41","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1128\/IAI.62.6.2432-2439.1994","article-title":"Expression of large amounts of neisserial porin proteins in Escherichia coli and refolding of the proteins into native trimers","volume":"62","author":"Qi","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.056_bib42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/jmbi.1999.3144","article-title":"Crystal structure of a Fab fragment in complex with a meningococcal serosubtype antigen and a protein G domain","volume":"293","author":"Derrick","year":"1999","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2005.07.056_bib43","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/0264-410X(95)00263-Z","article-title":"Immunization with meningococcal class 1 outer membrane protein produced in Bacillus subtilis and reconstituted in the presence of Zwittergent or Triton X-100","volume":"14","author":"Idanpaan-Heikkila","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.056_bib44","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/IAI.71.4.1650-1655.2003","article-title":"Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine","volume":"71","author":"Vermont","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.056_bib45","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1128\/IAI.65.12.5184-5190.1997","article-title":"Human B- and T-cell responses after immunisation with a hexavalent PorA meningocccal outer membrane vesicle vaccine","volume":"65","author":"Rouppe van der Voort","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.056_bib46","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/S0264-410X(03)00033-1","article-title":"Analysis of PorA variable region 3 in meningococci: implications for vaccine policy?","volume":"21","author":"Clarke","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.056_bib47","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.1128\/IAI.72.11.6503-6510.2004","article-title":"Development of immunity to serogroup B meningococci during carriage of Neisseria meningitidis in a cohort of university students","volume":"72","author":"Jordens","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.056_bib48","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1084\/jem.171.6.1871","article-title":"Deduced amino acid sequences of class 1 protein (porA) from 3 strains of Neisseria meningitides\u2014synthetic peptides define the epitopes responsible for serosubtype specificity","volume":"171","author":"McGuinness","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2005.07.056_bib49","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2958.1998.01056.x","article-title":"Naturally occurring insertional inactivation of the porA gene of Neisseria meningitidis by integration of IS 1301","volume":"30","author":"Newcome","year":"1998","journal-title":"Mol Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05007322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05007322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T17:09:48Z","timestamp":1586365788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05007322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0264410X05007322"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.07.056","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}